Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
about
Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk PatientsLong-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literatureImpact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men.Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression.Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma.Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.Bone demineralization in postmenopausal women: role of anamnestic risk factorsEffect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer PatientsProgressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study.Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer.Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma
P2860
Q26797677-5C4425FC-51E9-4FA0-9802-B59833133482Q33714084-B1C92D71-0222-49C8-AAAF-8A3C788E9000Q33984036-67AA3AD4-442D-427E-8994-7C01C83790FDQ35209461-4D6068EE-2F6E-4529-B92C-47B4C9BB9C60Q35760578-48E1B5D4-1D62-4E3D-B920-B9DA060F1C87Q36065371-A88FD661-61AF-469D-95D2-4CBFCE540B17Q36140993-61CB5FCE-A589-4B55-8B7D-DDEBE0482BDEQ36558392-F763BDC9-1CF1-4229-BB86-3005D3EC982EQ36606767-1E4EA79F-5933-44AD-9D77-6AC435367DD7Q37715020-3281005D-CB7A-45B1-BD35-5A28A8A6D81CQ38716870-E07B48B2-256A-472B-B87E-BB8F67CEEC4AQ47700549-0FAC4617-463B-4C5C-B170-15C76313F1BDQ57817289-A6E0BCA5-2A19-4145-8080-69FDED2058D3
P2860
Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@ast
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@en
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@nl
type
label
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@ast
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@en
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@nl
prefLabel
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@ast
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@en
Hip bone mineral density, bone ...... ferentiated thyroid carcinoma.
@nl
P2093
P356
P1476
Hip bone mineral density, bone ...... fferentiated thyroid carcinoma
@en
P2093
A Caroline Heijckmann
Jolanda de Vries
Maya S P Huijberts
Paul P C A Menheere
Piet Geusens
P356
10.1530/EJE.1.01933
P577
2005-07-01T00:00:00Z